Acetate Formulation (Hemodialysis Solution)

This solution is used for haemodialysis.

Composition

Calcium Chloride Dihydrate 0.5 %
Magnessium Chloride 0.4 %
Potassium Chloride 0.5 %
Sodium Acetate 18.1 %
Sodium Chloride 19.8 %

Calcium chloride is used to prevent or treat negative calcium balance. It also regulates action potential excitation threshold to facilitate nerve and muscle performance.

Potassium chloride is a major cation of the intracellular fluid. It plays an active role in the conduction of nerve impulses in the heart, brain and skeletal muscle; contraction of cardiac skeletal and smooth muscles; maintenance of normal renal function, acid-base balance, carbohydrate metabolism and gastric secretion.

Magnessium Chloride acts as cofactor in numerous enzymatic reactions involving protein synthesis and carbohydrate metabolism; depresses CNS, blocks peripheral neuromuscular transmission, produces anticonvulsant effects.

Sodium chloride is the major extracellular cation. It is important in electrolyte and fluid balance, osmotic pressure control and water distribution as it restores sodium ions. It is used as a source of electrolytes and water for hydration, treatment of metabolic acidosis, priming solution in haemodialysis and treatment of hyperosmolar diabetes. It is also used as diluents for infusion of compatible drug additives.

Recommended dose: 5 liters concentrate per dialysis or as required.

There are no known drug interactions and none well documented.

Known hypersensitivity to any of the ingredients of this preparation.

Fluid and electrolyte imbalance, hypovolemia, hypotension or muscle cramping may occur.

Pregnancy Category-not Classified. FDA has not yet classified the drug into a specified pregnancy category.

It is used for haemodialysis purposes only.

Haemodialysis solutions